Health : Page 32
June 5, 2023
Australia\'s New South Wales Ministry of Health (NSW Health) on Sunday issued a warning over meningococcal disease, urging locals to stay alert for related symptoms, after three cases have been recently reported across the state.
June 3, 2023
The Zimbabwean government has banned the importation, distribution, and sale of Johnson & Johnson\'s baby powder after it was found to cause cancer.
June 2, 2023
Starting June 1, 2023, people in British Columbia can get prescriptions from their pharmacist for contraceptives and medications to treat 21 minor ailments, such as allergies, shingles, cold sores, pink eye and uncomplicated urinary tract infections.
June 1, 2023
A team of University of Florida researchers has developed a promising new CRISPR-powered method for non-invasive blood tests that could help clinicians diagnose cancer at earlier stages.
May 31, 2023
Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide.
May 31, 2023
Providing people with accurate and timely information to help them take their prescription medications safely and effectively is an important priority for the U.S. Food and Drug Administration.
May 30, 2023
UK Government takes steps to crack down on rogue firms targeting children with free samples.
May 30, 2023
The Department of Water and Sanitation (DWS) says an investigation is underway into the source or sources of the cholera outbreak in the country.
May 29, 2023
Researchers from The University of Queensland have determined how Botox enters brain cells.
May 28, 2023
Novo Nordisk announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending once-weekly Sogroya (somapacitan) for replacement of endogenous growth hormone (GH) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency.
May 27, 2023
Elon Musk\'s brain chip company, Neuralink, has announced that it has received approval from the US Food and Drug Administration (FDA) to conduct its first tests on humans.
May 27, 2023
EMA’s human medicines committee (CHMP) has recommended revoking the marketing authorisation for Adakveo (crizanlizumab), a medicine for preventing painful crises (called vaso-occlusive crises) in patients aged 16 years and older with sickle cell disease.